TG Therapeutics Investigational Trial Site

Fayetteville, Arkansas 72703

Use our guide to learn which trials are right for you!

We've found
3 trials
at this facility
Chronic Lymphocytic Leukemia Clinical Trial
An Open-Label Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304
Status: Enrolling, Phase II
Updated: 1/13/2016
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Patients With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling, Phase III
Updated: 3/28/2016
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Patients With Untreated and Previously Treated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 3/31/2016
mi
from
Fayetteville, AR
Click here to add this to my saved trials